Medical Devices — Aug 31 – Sep 4, 2026 (Wk 36): Medical Devices: Earnings and Investor Events Drive Stock Movements

September 4, 2026 · · 6 min read
Weekly theme roundup · Aug 31 – Sep 4, 2026
Covering the 142 Medical Devices stocks in our database — browse every Medical Devices name →

TL;DR — This week in medical devices, several companies saw stock movements influenced by recent earnings reports, upcoming investor events, and broader market interest in defensive healthcare. The sector's risk score decreased slightly, indicating a moderate risk environment.

Theme risk
36/100 Moderate
▼ -6 vs last week
Median price / model value
1.00×
roughly fairly priced · 142 stocks
Insider tape (CMP-filtered)
0 buys
open-market, routine & 10b5-1 stripped

What moved

  • Johnson & Johnson's stock gained support, with one analyst raising its price target, as the company's earnings and guidance were viewed favorably and defensive healthcare stocks attracted investor interest. This highlights the appeal of established healthcare companies during periods of market uncertainty. [Investing.com Nigeria] [AD HOC NEWS]
  • Abbott Laboratories' stock also gained support following fresh earnings and guidance, indicating that positive financial updates can bolster investor confidence in large medical device manufacturers. [AD HOC NEWS]
  • CooperCompanies' stock edged higher as investors processed its latest quarterly figures, suggesting that recent financial performance continues to be a key driver for stock valuation in the sector. [AD HOC NEWS]
  • Conmed (CNMD) stock experienced a dip despite beating Q2 2026 expectations, as medical technology investors focused on the company's guidance. This illustrates that future outlook can sometimes outweigh past performance in influencing stock reactions. [AD HOC NEWS]
  • ICU Medical's stock dipped after a CFO share sale, with investors also considering the company's 2026 guidance. Insider transactions can sometimes be interpreted by the market as signals regarding a company's prospects. [AD HOC NEWS]
  • IRadimed's stock remained near its 52-week high as investors monitored growth metrics, indicating that strong growth can maintain investor interest and support higher valuations for medical device companies. [AD HOC NEWS]

The why behind the week

  • The movement in several medical device stocks this week was largely driven by the release of earnings reports and company guidance. These financial updates provide investors with insights into a company's current performance and future outlook, directly influencing stock valuations. [AD HOC NEWS] [AD HOC NEWS] [AD HOC NEWS] [AD HOC NEWS] [AD HOC NEWS]
  • Investor events and conferences, such as those scheduled for Merit Medical and AVITA Medical, serve as platforms for companies to communicate their strategies and performance to the market. These events can generate interest and provide clarity, which can impact stock activity. [Stock Titan] [Investing News Network]
  • The broader market's interest in defensive healthcare stocks, as seen with Johnson & Johnson, suggests that in certain market conditions, investors may seek stability in sectors less sensitive to economic cycles. This can provide a baseline of support for medical device companies. [AD HOC NEWS]
  • Comparisons of individual company stock performance, such as Becton, Dickinson and Company and Boston Scientific, against the broader medical devices sector help investors gauge relative strength and identify trends within the industry. [Barchart.com] [Barchart.com]
  • Dividend announcements, like the upcoming ex-dividend date for Vincent Medical Holdings, can also influence short-term stock trading as investors consider the timing of share purchases to qualify for dividend payments. [simplywall.st]

📄 Filings that matter (8-Ks, straight from EDGAR)

The macro backdrop

Overall market risk 41/100 Elevated

Every theme swims in this tide — judge the week’s moves against it.

What to watch next

  • The medical devices theme currently has a moderate risk score of 36/100, a decrease of 6 points from last week. This suggests a slightly reduced perceived risk for the sector, which could influence investor sentiment and capital allocation decisions. [SAVNG data]
  • The median price-to-model-value across 142 stocks in this theme is 1x. This metric indicates that, on average, stocks in the medical devices sector are trading at their modeled fair value, which can inform assessments of potential over or undervaluation. [SAVNG data]
  • There were no recorded open-market insider buys (routine/10b5-1 stripped) in the medical devices theme this week. The absence of insider buying can sometimes be noted by the market, as insider activity is often seen as an indicator of management's confidence in a company's future. [SAVNG data]
  • The overall market risk is currently at 41/100. This general market risk level can affect the medical devices sector, as broader market sentiment and risk appetite often have an impact on how investors view individual industries. [macro data]

This week’s headlines (sources)

Every claim above cites its source — headlines link to the original outlet; [SAVNG data] marks our own EDGAR-computed figures. Where our sources don’t explain a move, we say so rather than guess. All weekly roundups →

All Medical Devices roundups: 2026-W37 · 2026-W35 · 2026-W34 · 2026-W33 · 2026-W32 · every scope →

SAVNG is an educational research publication, not a Registered Investment Adviser. Everything here is general-circulation information produced by an automated pipeline — the same for every reader — and is not personalized investment advice, an offer, or a recommendation to buy or sell any security. Any performance figure is hypothetical; past performance does not predict future results. Details.

Get next week's roundup automatically

Get these in any reader — no email, no account. Paste a link into Feedly, Inoreader, NetNewsWire, or your browser.